Lung Cancer Drugs Market Seeking Excellent Growth | Pfizer, AstraZeneca PLC, Eli Lilly
iCrowd Newswire
12 May 2021, 07:54 GMT+10
A new 93 page research study released with title Lung Cancer Drugs Market provides detailed qualitative and quantitative research to better analyze latest market scenario and staged competition. The study not just covers geographic analysis that includes regions like North America, Europe or Asia but also players analysis with profile such as F. Hoffmann-La Roche Ltd, Bristol–Myers Squibb, Janssen, Amgen, AstraZeneca PLC, Pfizer, Inc., Eli Lilly & Company Ltd, and Novartis AG With n-number of tables and figures examining the Lung Cancer Drugs Market, the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader s market revenue forecasts as well as analysis to 2026.
By TMR Research on May 4, 2021
This market research report includes a detailed segmentation of the global fetal and neonatal equipment market by product types (fetal care equipment, neonatal care equipment, and others), by end-users (hospitals, pediatric hospitals, and NICU centers), and by regions (North America, Europe, APAC, and RoW).
Research Overview
Infoholic Research predicts that the global fetal and neonatal equipment market will grow at a CAGR of 7.4% during the forecast period. The market is classified into different product categories: patient monitoring, diagnostic devices, warmers, incubators, and phototherapy equipment’s. The rise in patient monitoring especially fetal and neonatal care equipment’s have seen an increased adoption in basic to advanced equipment’s across globe. The rise in adoption of such devices in developing countries with various agreements and policies have helped the market to grow faster. Fetal and neonatal care equipment’s are mostly